$POAI Secures $15 Million Equity Line

$LXRP Marijuana Stocks Targeting the Cannabis Beverages Market

This special piece features clients of Cannabis Investing News

In December 2019, just over a year after the legalization of adult-use cannabis, Canada will undergo a second wave of cannabis legalization.

While Canadians were initially denied the right to enjoy tasty cannabis treats, the national market will soon see a wave of edible cannabis products and infused beverages. The most refreshing of these new product offerings will be cannabis beverages. Cannabis companies and long-running beverage companies alike are seeing major opportunities in the cannabis beverage market. Soon there will be a “cannadrink” for just about every type of cannabis consumer to raise a glass to the next wave of legalization.

Cannabis beverages could cause major disruption for both the beverage industry and the cannabis market. Some of the biggest names in the beverage market have either shown interest or made concrete plans to get into cannabis in one form or another. Coca-Cola (NYSE:KO) is reportedly watching the CBD functional beverage market closely. Most of the major international brewers, like Constellation Brands (NYSE:STZ), AB InBev (NYSE:BUD) and Molson Coors (NYSE:TAP), have partnered with cannabis producers with plans for infused beers. Arizona Beverage Company has also partnered with a producer to develop infused versions of its iconic iced teas.

The global cannabis beverage market is projected to be worth US$5.04 billion by 2026, and it’s not just big names in the beverage industry that stand to gain. Cannabis companies of all types and sizes are finding their place in what could be the next big cannabis growth driver. Cannabis-focused investment company Redfund Capital (CSE:LOAN,OTCQB:PNNRF,FWB:O3X4), for example, has created a division specifically for cannabis beverage companies in anticipation of a rush of opportunity in this space.

People have been consuming beverages for a psychoactive or functional effect for thousands of years. For consumers seeking an alternative to smoking or vaping, enjoying cannabis as a beverage replicates the experience of cracking open a beer or canned spirit, something with which most adult consumers are already familiar. Additionally, the beverage space provides companies with ample opportunity for product differentiation with countless options for different flavors and styles.

Marijuana stocks targeting infused beverages

Some of the earliest interest in cannabis beverages has come from the beer industry. With the traditional beer market stagnating in recent years, major brewers are likely looking at the emergence of cannabis beer as a much-needed shakeup in the industry. In addition to creating a novel product category, non-alcoholic cannabis beers could help win back the segment of young consumers who have been increasingly reducing or ceasing their alcohol consumption in the name of health consciousness.

The emergence of a new category in the beer market creates an opportunity for new players to enter the market. Hill Street Beverage Company (TSXV:BEER) has developed a line of non-alcoholic beers and wines that can be infused without impacting the taste, smell and quality of the beer. Hill Street says that the psychoactive effect of its beers mimics the onset time, duration and intensity of traditional alcoholic beers. Hill Street is also one of the first companies in Canada to develop non-alcoholic cannabis wines.

Not every consumer is a beer drinker, however, so the cannabis market is also expected to offer a wide range of soft drink-style cannabis beverages. The flavor possibilities for these soft drink-style drinks are as varied as the drink section of even the most well-stocked convenience store, which is expected to create plenty of opportunities for emerging cannabis beverage companies to find their own niche.

BevCanna Enterprises (CSE:BEV) has developed two beverage lines for the adult-use infused soft drink space: the THC-dominant, fruit-flavored Anarchist Mountain and the milder CBD/THC balanced Gruv iced tea. Other companies that are currently developing their own unique takes on cannabis-infused soft drinks include Sire Bioscience (CSE:SIRE,OTC:BLLXF,FWB:BR1B), Geyser Brands (TSXV:GYSR), Acreage Holdings (CSE:ACRG,OTCQX:ACRGF,FWB:0VZ), Mojave Jane Brands (CSE:JANE,OTC:HHPHF,FWB:0HCN), Pure Global Cannabis (TSXV:PURE,OTC:PRCNF,FWB:1QS) and Matica Enterprises (CSE:MMJ.CN,OTCQB:MMJFF,FWB:39N).

Cannabis drinks will not be limited to the adult-use recreational market. One of the biggest stories of the legal cannabis industry as a whole over the last few years has been the emergence of non-psychoactive CBD products. CBD’s popularity has exploded in recent years as a treatment for chronic pain, inflammation and anxiety without the characteristic high of THC. These properties make CBD ideal for the functional beverage market. CBD drinks are being formulated as sports drinks to relieve post-workout soreness and as health drinks that offer nootropic benefits.

BevCanna produces a line of CBD-dominant fruit drinks under the company’s Lev brand. Harvest One Cannabis (TSXV:HVT,OTCQX:HRVOF) has purchased a line of sleep-aid drinks called Dream Water and intends to add CBD-infused drinks to the brand. Nutritional High International (CSE:EAT,OTCQB:SPLIF) has developed HempOmega, a hemp-based nutritional supplement that can be added to beverages. Companies like TransCanna Holdings (CSE:TCAN) are partnering with breweries to produce CBD-infused non-alcoholic beers as well.

Extraction and infused beverages

Many of the companies producing cannabis beverages are focused on the formulation side of beverage development, leaving it up to specialized cannabis extraction companies to produce the active ingredients for their beverages. Beverage producers are partnering with extractors, often using proprietary methods to produce the optimal cannabis extract for their particular beverages.

Cannara Biotech (CSE:LOVE,OTCQB:LOVFF,FWB:8CB) is providing extraction services for a number of edibles and beverages partners, including a microbrewery in Quebec. Chemesis International (CSE:CSI,OTCQB:CADMF,FWB:CWAA) is providing extraction services for cannabis beverage makers as well. Growth in the cannabis beverages market could mean big opportunities for diverse cannabis companies like GTEC Holdings (TSXV:GTEC,OTCQB:GGTTF,FWB:1BUP), which offers third-party analytical testing for the medical cannabis, environmental and food industries. Valens GroWorks (TSXV:VGW,OTCQX:VGWCF) and Nextleaf Solutions (CSE:OILS,OTCQB:OILFF,FWB:L0MA) have also developed proprietary extraction technologies to serve the cannabis beverage industry.

The way cannabis is infused into a beverage can have a major impact on the quality of the final product. Earlier renditions of cannabis beverages were known for an unpleasant “weedy” taste caused by lingering plant matter in the extracted cannabis. Today, cannabis technology companies are finding new ways to put cannabis drinks together so that the consumer only tastes the ingredients that are meant to be tasted. To make sure its cannabis beers taste like beer and not cannabis, Hill Street Beverage company has partnered with Lexaria Bioscience (CSE:LXX,OTCQX:LXRP) to provide extraction services. Lexaria’s proprietary DehydraTECH is capable of removing the taste and odor of a cannabis extract before infusing it into a beverage.

Takeaway

Cannabis beverages could become one of the hottest cannabis product categories after the second wave of cannabis legalization allows them into the Canadian market. The beverage space creates opportunities for innovative and distinctive products that are varied enough to appeal to the tastes of just about any cannabis consumer. After a year of cannabis legalization, infused beverages could provide the refreshment needed to drive the cannabis market forward.

Disclaimer: Redfund Capital, Hill Street Beverage Company, BevCanna Enterprises, Sire Bioscience, Geyser Brands, Acreage Holdings, Mojave Jane Brands, Pure Global Cannabis, Matica Enterprises, Harvest One Cannabis, Nutritional High International, TransCanna Holdings, Cannara Biotech, Chemesis International, Valens GroWorks, Nextleaf Solutions, Lexaria Bioscience are clients of the Investing News Network. 

The companies selected for this article are clients of the Investing News Network and were selected as each of them are developing their businesses in the Canadian cannabis market in the lead up to the legalization of the recreational market on October 17, 2018.

This article was written according to INN editorial standards to educate investors.

$POAI TumorGenesis Technology May Prove Critical in New Cancer Drug Development

November 19, 2019

$SRAX BIGtoken App Makes Owning, Monetizing Personal Data Possible

$GNPX Preclinical Data, Positive Results in Resistant Metastatic Lung Cancers

$TGODF Significantly Expands Canadian Distribution Footprint

$SGLB Profiting from the Fourth Industrial Revolution

November 19, 2019

$CNPOF $RIV.V Construction Starts on First Hemp and Cannabis Supply Chain in Canada

November 19, 2019

On Friday Morning, Grasslands Taber Collaborative (GLTC) located in the Town of Taber, Alberta launched the construction of the first marijuana, hemp, and infused agricultural food supply chain in Canada. The GLTC Premium Park Project partnerned with rural communities in the western part of Canada to capitalize on the business opportunities found in the new marijuana sector.

They will be producing marijuana and agricultural foods. GLTC will also provide farmers with research, development, and processing opportunities, as well as rental spaces for producers and other businesses.

GLTC CEO, Lindsay Blackett, said that the Premium Park’s primary purpose is to produce premium weed and premium infused products. In a tweet, she said that the company has attracted much interest from companies across the globe, especially in the U.S.

The GLTC Premium Park will be located at the heart of Taber, Alberta. The facility will be constructed on a 60-acres plot along Highway 36. The activities taking place at the facility include cultivation, extraction, processing, and distribution.

The park will be installed with a state-of-the-art extraction facility certified for extraction of both marijuana and hemp by Health Canada and the European Union Good Manufacturing Process (GMP). Natural Health Products will also issue certification to the GLTC extraction plant.

The president of Taber and District Chamber of Commerce, Joanne Sorensen, said that the announcement of the construction of the GLTC Premium Park would be a significant boost for the economy in Taber. She also noted that the town has been experiencing an economic downturn forcing businesses to move, and the remaining companies complained about getting close to zero profits.

Historically, the Town of Taber has always been interested in the marijuana business. Last year, the council voted 4-3, allowing the opening of marijuana dispensaries in Taber. However, the GLTC Premium Park Project had the support of all the town officials, when making its announcement on Friday.

The mayor of Taber, Andrew Prokop, said that the GLTC project is a win-win for the town because it will provide employment opportunities to about 200-300 individuals residing in Taber. He also noted that through the GLTC project, the local economy would be diversified.

The Director of Planning and Economic Development in Taber, Phyllis Monks, said that the impact of the Premium Park would benefit the whole of Taber town.

Sorensen further said that once the construction starts in spring, more than 200 people are expected to secure employment. She also noted that it is not a wonder to see families moving to Taber and renting or building their own homes and bringing more business opportunities with them.

There will be 25 slots for sale ranging from 1.5 to 5 acres and a retail mall in the GLTC Premium Park facility.

It is these sorts of developments that make hemp industry experts to agree with industry players, such as Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Sugarmade Inc. (OTCQB: SGMD), who say that hemp and its associated activities can bring immense economic benefits to any area where it is legalized.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$OGI This is Why CBD Will Remain One of the Hottest Investment Stories

November 19, 2019

Palm Beach, FL – November 19, 2019 — International support for CBD has been explosive.  At the moment, one in seven Americans say they personally use cannabidiol-based products, says a recent Gallup poll, which has only proliferated since the passage of the U.S. Farm Bill.  However, those numbers are likely to increase as more CBD makes its way on to shelves. In fact, the Brightfield Group estimates the U.S. CBD product market alone to be worth over $23.7 billion by 2023, as CBD finds its way into a variety of consumer product categories including  food and beverage, pharmaceuticals, cosmetics, and health and wellness.  In Europe, one in six Europeans surveyed by New Frontier Data reported using CBD.  In addition, nearly half of Europeans reported having a positive impression of CBD.That’s leading to a wide range of opportunity for companies including CBD Global Sciences, Inc. (CSE: CBDN), OrganiGram Holdings Inc. (TSX-V:OGI)(NASDAQ:OGI), Zenabis Global Inc. (OTCPK:ZBISF)(TSX:ZENA), KushCo Holdings Inc. (OTCQB:KSHB), and cbdMD Inc. (NYSE:YCBD).

CBD Global Sciences, Inc. (CSE: CBDN) BREAKING NEWS:  CBD Global Sciences, Inc. announced the expansion of its Aethics Hydration product line, launching an all new lineup comprised of infused CBD Balance Sparkling Water in 3 flavors – Grapefruit, Berry, and Lemon Lime.  With today’s launch of the expanded Aethics Hydration product line, CBD Global Sciences’ aim is to increase its market share in the rapidly growing market segment for hemp-derived CBD sports water. CBD-infused beverages are considered to be the fastest growing segment in the overall market. According to market research firm, Zenith Global, the U.S. cannabis-infused drinks market will reach an estimated $1.4 Billion by 2023. CBD Global Sciences’ water line can be viewed and purchased online at https://aethics.com/products/cbd-sparkling-water-for-athletes-by-aethics-h20-balance, and is available through retail outlets nationwide.

The Company’s Sparkling Water is a 12-ounce cannabis infused with 10mg of CBD and flavor extract.  The H2O Balance Sparkling water uses a refined full-spectrum formulation to preserve the full range of the hemp-plant’s beneficial components. Brad Wyatt, CEO & President, states “ Our company continues to demonstrate its ability to be timely and innovative in creating multiple varieties for our hydration lines that will enhance the consumer’s ability to find a product that they will enjoy as a refreshing way to rehydrate with a full spectrum compliment of CBD and other supportive cannabinoids.”

Other cannabis-related developments from around the markets include:

OrganiGram Holdings Inc. (TSX-V:OGI)(NASDAQ:OGI) announced details for its fiscal fourth quarter ended August 31, 2019 and full year 2019 conference call. The Company is scheduled to report its fourth quarter and full year earnings results for its fiscal year ended August 31, 2019 on Monday, November 25, 2019 before market open.  For the fiscal full year 2019, the Company expects to report year-over-year growth in net revenue of approximately 547% to about $80.4 million as well as positive adjusted EBITDA for the year. Net revenue (after excise taxes) for Q4 2019 is expected to be approximately $16.3 million, which reflects about $20.0 million of shipments in the quarter and about $3.7 million in provisions for product returns and pricing adjustments. Lower Q4 2019 net revenue (compared to third quarter net revenue of approximately $24.8 million) and about $1.6 million of packaging and inventory adjustments (charged to cost of sales) in the quarter are expected to contribute to negative adjusted EBITDA for Q4 2019.For Q4 2019, the Company also expects to report sequential improvement in the cost of cultivation per gram and overall harvested volume as its yield per plant returned to normalized levels following a temporary decline in the third quarter of fiscal 2019 (“Q3 2019”). As first discussed in its third quarter earnings report, the cannabinoid content in Organigram’s harvested flower and sweet leaf has continued to reach all-time highs and the Company has identified what it views as an optimal balance of high yields and high cannabinoid content. “While Q4 2019 did not meet our overall expectations, we have not only emerged as one of the national leaders in the industry with significant growth expected in net revenue and strong market share, we expect to report positive adjusted EBITDA for the year,” said Greg Engel, CEO. “And we remain relentlessly focused on running a profitable business which earns attractive returns on investment for our shareholders over the near and long term. We are encouraged by Ontario’s recent announcement to expand the retail network and believe this should be an important catalyst to drive further growth for us and the industry as a whole.”

Zenabis Global Inc. (OTC:ZBISF)(TSX:ZENA) CEO Andrew Grieve stated, “ “In this quarter, Zenabis substantially expanded its licensed capacity and cultivation yields, raised $65 million in new financing, and submitted further license amendments that, once approved, will increase annual cultivation capacity by over 300% compared to the second quarter of 2019. These license amendments at Zenabis Altholville and Zenabis Langley, expansion into the Ontario market, and the launch of a new value brand Re-Up meaningfully improved our competitive position for the fourth quarter and beyond.” Mr. Grieve added, “We continue to make substantial progress toward achieving our planned licensed annual production capacity of 143,200 kg. By the end of 2019, we expect to have 111,200 kg of capacity licensed or submitted for licensing. In addition, we resolved our packaging challenges in September of 2019. As a result, October provincial recreational shipments increased by 93% to 830 kg versus 430 kg in September of 2019, and primary dried flower packaging output per day increased by 101% to an average of 10,636 units per day in October 2019 versus 5,282 units per day in September 2019. Over the first 10 days of November, this figure increased to an average of 18,099 units per day.”

KushCo Holdings Inc. (OTCQB:KSHB) Co-founder, Chairman and Chief Executive Officer, Nick Kovacevich commented, “”Since we became a public company in 2016, we have more than doubled our annual revenue in each of the last four fiscal years, with revenue for fiscal 2019 increasing 186% year-over-year to a record $149.0 million, helping us achieve our guidance of between $145 million and $150 million in revenue. Substantially all of this robust growth was organic, driven primarily by our continued success in penetrating both new and existing markets and cross-selling deeper into our 6,000+ strong customer base with our significantly expanded offerings. Perhaps more importantly, we have supplemented this solid topline growth with increasing margins, as we have driven further improvements and efficiencies in our business. In fact, our gross margins have been increasing every quarter since we started fiscal 2019 from 13% in fiscal Q1 to 20% in fiscal Q4. Given that we are continuing to gain scale and efficiency in our core business, while launching and ramping up higher-margin service offerings, we expect to see continued gross margin enhancement in the near future.”

cbdMD Inc. (NYSE:YCBD) announced today that in tandem with its strong sequential sales growth recently reported, the company has also been ranked the highest in several key categories within the CBD industry.  “We are excited to announce that according to the Brightfield Group, one of the leading predictive analytics and market research firms for the legal CBD industry, in a newly released survey conducted by Brightfield of more than 3,500 CBD users, cbdMD ranked the highest in terms of overall consumer satisfaction as well as the highest in unaided consumer awareness of any of the top 20 CBD brands. In addition, according to media intelligence and monitoring company Meltwater, cbdMD had the highest “share of voice” throughout the entire CBD Industry for the three months ended September 30, 2019,” said Martin Sumichrast, Chairman and co-CEO of cbdMD, Inc. “We believe that this clearly shows that our brand building and marketing efforts are leading the CBD industry. This data should accelerate our push into retail as more and more retailers are getting onboard with our brand. Our goal has always been to have the leading brand in the space, with the best products and industry leading customer service. I believe that we are delivering on that promise everyday.”

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM was compensated thirty five hundred dollars for news coverage of current press releases issued by CBD Global Sciences Inc., by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$YGYI Financial Results for Three and Nine Months Ended September 30

$LXRP Cannabidiol Can Help to Manage Endometriosis Pain, New Study

November 18, 2019

Cannabidiol (CBD) is a cannabis extract with remarkable medicinal properties, and for the past few years, it has kept the world enthralled. It is often confused for THC (delta-9 tetrahydrocannabinol), the component responsible for cannabis’s famous high, but CBD is non-psychoactive, and it doesn’t make users high. Instead, the compound acts as a potent and versatile medicine, working against a variety of conditions ranging from anxiety and high blood pressure to chronic pain and rare childhood epilepsies. However, it has only been researched to a limited degree, and there is still a lot about CBD that we still don’t know. Results from a recent study show that CBD may also help women seeking relief from endometriosis-related pain.

The study was presented at the 2019 American Association of Gynecologic Laparoscopists (AAGL) Global Congress in Vancouver, Canada. Its primary goal was quantifying the rate of cannabis and cannabidiol use among endometriosis patients, as well as its effectiveness. The REDCap Survey was conducted online, and participants were invited through email to answer a list of 50 to 75 questions based on branching logic. Most of the participants were either identified through a mailing list for the Endometriosis Association or an ICD-10 code for endometriosis diagnosis at a clinic.

“Our participation was very different between our two groups. The invitation stressed that this was an anonymous survey, but I think there’s still a taboo around this topic,” says Anna Reinert, MD, the presenting author of the study. Two hundred forty people from the Endometriosis Association replied, and 77 (32.1%) of them reported having tried cannabis before, with 52 of the 72 saying the cannabis was very or moderately effective. Sixty-seven people said they had tried CBD, and for 50% of them, it was very or moderately effective at reducing pain. Fifty-seven patients from the clinic had tried CBD in the past, and 64% of them said it had been very or moderately effective.

Over the years, more people have turned to CBD to help manage their pains. A study published in the European Journal found that CBD reduced inflammation and pain in rats and that it might also be applicable in humans. Another report stated that there was substantial evidence that cannabidiol could be used to manage chronic pain in adults.

However, Dr. Reinert says that “further research is needed to explore the potential benefits and clarify the limitations and risks of the use of cannabis for the management of chronic pelvic pain and endometriosis.”

Such research findings make analysts to believe that industry players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) are more than justified to strongly affirm that cannabidiol has immense health benefits that could even take decades to fully understand.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$TGODF Cannabis Weekly Round-Up: Quarterly Updates Rock Market

During the past trading week (November 11 to 15), a steady release of quarterly updates from cannabis companies caused a spike in volatility in the sector.

Also during the period, a critical acquisition deal in the US market was revealed to be moving forward with new terms, while a marijuana producer passed the blame for its poor sales to the provincial rollout of cannabis stores in Ontario.

Here’s a closer look at some of the biggest cannabis news over the last week.

Earnings season hits the market

The cannabis stock market faced a week of volatility as companies in the space presented reports on their most recent quarterly data and performance.

Some highlights of this earnings season include the increasing tension producers are feeling about the rollout of retail stores in Ontario. Companies like Canopy Growth (NYSE:CGC,TSX:WEED) have said the process has stunted the growth of the industry following legalization in Canada.

“We do not believe at this time that there will be sufficient points of retail sales in the near term to unlock the necessary Q4 demand,” Canopy Growth CEO Mark Zekulin said.

Fellow producers Cronos Group (NASDAQ:CRON,TSX:CRON) and Aleafia Health (TSX:ALEF,OTCQX:ALEAF) experienced drops in their share prices after releasing their respective financials.

While Cronos celebrated the launch of its hemp-derived product brand in the US, the firm missed analyst targets in its most recent quarter.

Aleafia Health achieved new low prices for per gram cultivation, yet the open market was not too impressed with the firm’s steady results.

Just before releasing its quarterly results, The Green Organic Dutchman Holdings (TSX:TGOD,OTCQX:TGODF) obtained C$103 million in funding by way of separate brand new transactions. Similarly, The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) announced alongside its quarterly results that it has secured a C$90 million senior secured credit facility, with the Bank of Montreal (NYSE:BMO,TSX:BMO) acting as lead arranger for a group of lenders.

These weren’t the only releases to come out over the past week. Investors were also treated to quarterly updates from Aurora Cannabis (NYSE:ACB,TSX:ACB), Halo Labs (NEO:HALO,OTCQX:AGEEF) and Jushi Holdings (NEO:JUSH.B,OTCQX:JUSHF).

Cresco and Origin House set new deal terms

Cresco Labs (CSE:CL,OTCQX:CRLBF) and Origin House (CSE:OH,OTCQX:ORHOF) have rearranged the terms of their proposed acquisition transaction.

As part of the new arrangement, which comes on the heels of the deal clearing its federal antitrust review period, Cresco will lower its offer to 0.7031 of its own shares for each Origin House share.

The California-based cannabis distributor is now being required to also complete a financing deal of over 9.7 million of its own common shares at C$4.08 per share, totaling C$39.6 million.

“The equity market environment has changed meaningfully since we first announced this proposed transaction. While this has presented challenges, it will also present opportunities for companies with quality assets and brands to quickly gain market share and build long-term shareholder value,” Marc Lustig, CEO of Origin House, said.

The deal was previously put on hold due to a federal antitrust review in the US, which Cresco CEO Charlie Bachtell referred to in August as a chance for the cannabis company to showcase the intricacy and maturity of the sector.

Market updates

Organigram Holdings (NASDAQ:OGI,TSX:OGI) faced a week of declines after sharing new guidance. The company is now projecting a drop of C$8.5 million for its quarterly revenues.

Similar to many struggling companies in the sector, Organigram blamed a large portion of its woes on the lack of retail stores in Ontario — a key marijuana market.

“The lack of a sufficient retail network and slower than expected store openings in Ontario continued to impact sales in Q4 2019 and were further exacerbated by increased industry supply,” Organigram said in its statement on Monday (November 11).

Meanwhile, the provincial government in British Columbia plans to introduce a 20 percent tax on all retail sales of vape cannabis products as part of the second stage of legalization in the country.

The actual items in question to be taxed will include vaping devices, vaping substances, cartridges, parts of the devices and accessories. The new tax will come into effect in British Columbia on January 1, 2020. These products won’t become available throughout Canada until mid-December.

“It is imperiling the success of legalization,” Cannabis Council Vice Chair Cameron Bishop told Marijuana Business Daily. The agency, which is tasked with representing the interests of licensed producers, expressed its disappointment with the new tax.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

$BHAT Announces Entry into Second Phase Development of Immersive Educational Materials

$YGYI Conference Call to Review Financial Statements and Corporate Update

Earnings Results for 2019 Third Quarter and Nine-Month Ending will be Released after the Close of the Market Today

SAN DIEGO, Nov. 18, 2019 — Youngevity International, Inc. ( NASDAQ :YGYI ) (www.ygyi.com) a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, announced today that it will host a conference call today, November 18, 2019 at 4:15 PM Eastern Standard Time, (1:15 pm Pacific Standard Time), to discuss the Company’s financial results for the quarter ending September 30, 2019, which it plans to release that day.

Youngevity International’s senior management will host the call, led by Mr. Steve Wallach, Chairman and Chief Executive Officer and joined by Mr. Dave Briskie, President and Chief Financial Officer as well as Joshua Carmona, Executive Vice President of Khrysos Industries. The purpose of the call will be to discuss its financial results, provide an update on current business trends and to answer questions that are submitted by shareholders, analysts, and other interested parties.

Business Update Conference Call and Webcast Information

Individuals can participate in the conference call by dialing 1-877-870-4263 (Toll Free) or 1-412-317-0790 (international) and refer to the “Youngevity International Call”  The webcast will be accessible in the Investors section of the Company’s website at https://ygyi.com/. The archived webcast will be available for replay on the Marker website approximately one day after the event.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a multi-channel lifestyle company operating in 3 distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise.  The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI Investor Relations
800.504.8650
investors@ygyi.com

$SGLB Transforming the Creation of Critical 3D Metal Printing Components

• Sigma Labs is revolutionizing the 3D metal printing process by reducing and in certain cases eliminating the need for costly and wasteful post-production inspections
• PrintRite3D software is first and only system that enables real-time, in-process detection of manufacturing irregularities for critical metal parts, provides real-time quality assurance using advanced visualizations to fix process and part irregularities.
• Sigma Labs’ IP portfolio covers advanced in process quality metric (IPQM) algorithmic techniques for the additive manufacturing laser powder bed quality control industry
• Company targets a growing multibillion-dollar global total addressable market
• Negotiating for lucrative machine OEM partnerships to advance “closed loop” technology roadmap
• Tier-1 OEM enterprises and end-users such as Airbus, Baker Hughes, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
• Sigma Labs technology team has developed an inclusive machine technology platform for all machine species that is capable for Single, Dual and Quad Laser machines on multiple OEM platforms.

Sigma Labs Inc. (NASDAQ: SGLB), a developer of latest-generation, non-destructive quality inspection systems for metal-based additive manufacturing and other advanced manufacturing technologies, is set to revolutionize 3D metal printing by eliminating the need for costly post-production inspections and ensuring quality control during the manufacturing process.

3D metal manufacturing or additive manufacturing utilizes lasers to sculpt parts by welding powdered metals into 3D objects. Quality of these parts can vary from machine to machine in a production line and even from part to part in a single production run. Conventional quality assurance methods rely on…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$POAI Reports Q3 Results, 58% Revenue Increase

$YGYI How to Engage Your Customers and Build Loyalty for Your CBD Brand

November 15, 2019

Cannabidiol (CBD) has been having a magnificent run for the past couple of years. The cannabis extract is, without a doubt, one of the most versatile and potent naturally-occurring medicines we’ve encountered in decades, if not centuries. Said to be effective against a variety of medical conditions ranging from high blood pressure to chronic pain and childhood epilepsy, CBD has been subject to intense interest over the years.

Naturally, a plant with such diverse medical benefits couldn’t be slept on for too long. The 2018 Farm Bill termed cannabis with less than 0.3 THC as industrial hemp, making its cultivation, marketing, and sale legal. This was followed by the USDA’s interim rule on hemp in October 2019, further rounding out the sector’s regulations. The result was an influx of supply, with everyone from hemp farmers to CBD processors looking to cash in on the lucrative market. So, how do you stand out from the rest of the pack? How do you get consumers to pick your product and stick with it?

For starters, monitor the web for CBD developments. Technology has made keeping tabs on anything as simple as the touch of a button. You can use Google Alerts to keep yourself abreast of any and all worldwide developments on CBD. Changes in regulations or additional rules can be announced at any time, and it’s essential to stay on top of avoid getting caught unawares.

Don’t forget about your online presence. Dr. Diane Mulligan, APR president of M&C Communication says, “When you position your CBD company as a trusted resource, we find that basing messaging and customer outreach on honesty, accuracy, and truth as outlined in the Public Relations Society of America Code of Ethics, provided a great framework, especially when talking about an emerging markets such as CBD. ”

Educate your audience. The CBD industry is in a state of constant flux, and interested consumers want to stay updated on all developments as soon as possible. If your communication streams contain dated or incorrect information, chances are you’ll be passed over for a more current and in touch brand. Mulligan says that you have to educate and build trust in your target audience, which will lead to loyalty in both the B2B and B2C segments of the market.

Stick to the 80/20 rule. One mistake many businesses make on their communication channels is overselling. However, the best way to keep prospective consumers interested and engaged is to make your content 80% educational, and 20% promotional. Nobody likes an overaggressive seller, but if you can teach them about the product and help them understand it, chances are they’ll buy from you.

The CBD market is a big one, and it is projected to grow even further. Implementing a few of these tips will help you stand out from the pack and build a strong brand.

One wouldn’t be surprised if successful CBD brands like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Youngevity International Inc. (NASDAQ: YGYI) have mastered and even added onto the strategies above in reaching and retaining their target markets.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$TGODF Investor Ideas Potcasts, Cannabis News and Stocks on the Move

Delta, Kelowna, BC – November 15, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM – cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/111519-StocksToWatch.mp3

SHARE PODCAST:

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, Athletes For CARE (A4C), the leading athlete support care organization announced their brand new Canadian Medical Cannabis Patient Support Program. This innovate and simple-to-use support system will allow athletes to have easier access to medical cannabis prescriptions and treatment, as well as key tools that will support them throughout their journey with medical cannabis.

Athletes for CARE is a not-for-profit organization with a community of athletes finding support, opportunity and purpose in life after a career in sports by using their influence for social change. Founded in 2016 by passionate individuals who recognized the need to advocate for the health, safety and wellbeing of more than 2 billion people of all ages who compete annually in sanctioned sports globally.

“We’re excited to bring this new medical cannabis support program to life for our Canadian athletes,” said Christina Michael, Director, Canadian Activation, Athletes for CARE.

“This further strengthens our growth and ability to improve the health and wellness options for individuals who may be living with physical and mental health challenges and looking to medical cannabis as a potential therapeutic option to help.”

The organization will be working alongside Strainprint® Technologies Ltd. (Strainprint), the leader in medical cannabis data and analytics to support patients with an Athletes For CARE version of the Strainprint app. The companion and mobile journaling tool will help patients understand which strains and ingestion methods work best for them.

“With more than 70 million data points and 1.4 million tracked medical cannabis patient outcomes and real-world observational data, we know that current and retired athletes often face a multitude of pain and stress related issues. By aligning with Athletes for CARE we’ll be able to provide a real-time strain recommendation guide and journaling tool that can help athletes easily determine which strain is best suited to treat their symptoms,” said Jessica Moran, Director, Marketing & Communications for Strainprint. “Our organization has been created by patients for patients, and we see this as the beginning of an exciting relationship with Athletes for CARE. In addition to providing patient support, we look forward to a future of our mutually shared vision in advancing medical cannabis research throughout the entire athletic community.”

Athletes for CARE is also excited to announce the involvement of Dr. Mike Hart, Cannabis Physician and Lifestyle Strategist who in addition to participating as an Ambassador for Athletes for CARE will be providing medical services and treatment guidance to A4C athletes.

“Most athletes have experienced a tremendous amount of physical trauma that has caused pain, insomnia and poor recovery. Fortunately, many athletes have responded favourably to cannabis; I believe every athlete should be offered cannabis as first-line treatment,” said Dr. Hart. “I am excited to broaden my support of the athletic community through Athletes for CARE and I am equally passionate about their mission to unite the athletic community for support, research and education.”

VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF) released its third quarter 2019 financial and operating results.

VIVO’s net revenue increased to $6.3 million during Q3 2019, a 19% increase relative to Q2 2019, reflecting the ramp-up of the Company’s increased licenced capacity which is expected to result in further revenue growth in Q4 2019. VIVO also continued to sustain top-tier prices for its dry flower products, with a net average selling price of $7.15 per gram in Q3 2019.

Adjusted EBITDA was ($2.1) million in Q3 2019 compared to ($1.2) million in Q2 2019, primarily attributable to some one-time expenses, including those associated with VIVO’s ramp-up of increased licenced capacity. As at September 30, 2019, cash and cash equivalents (excluding strategic equity investments) were approximately $50 million.

“Our focus for the first half of the year was to satisfy the needs of the evolving adult-use market, provide consistent supply of quality products to medical patients, and execute our plans for cannabis 2.0,” commented Barry Fishman, Chief Executive Officer of VIVO. “We continue to execute against our four strategic priorities and are sharply focused on accelerating our path to profitability.”

Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) announced its financial results for the third quarter and nine-month period ended September 30, 2019.

Produce sales were US$38.3 million compared with US$39.7 million and the company had a net loss before tax of (US$6.5 million) and included the loss from Pure Sunfarms Corp. of (US$0.9 million). Loss per share was (US$0.10) compared with loss per share of (US$0.04) and EBITDA loss was (US$2.4 million), including the positive contribution from Pure Sunfarms of US$5.0 million (C$6.6 million), this compares with an EBITDA loss of (US$2.0 million); and subsequent to quarter end, completed a bought deal offering of 3,059,000 common shares at a price of C$9.40 per share for aggregate gross proceeds to the Company of C$28,754,600.

“We are pleased to report another quarter in which Pure Sunfarms continued to set the standard for performance as a best-in-class cannabis operation, which again drove strong financial performance,” said Michael DeGiglio, Chief Executive Officer, Village Farms. “Pure Sunfarms’ achieved its fourth consecutive quarter of positive EBITDA, with an industry leading all-in cost of production of C$0.63, gross margin of 69% and EBITDA margin of 56%. In the 12 months since adult-use cannabis was legalized in Canada in October 2018, Pure Sunfarms has already generated C$47 million in EBITDA, an especially impressive number given that its operations were ramping up throughout most of that period.”

“Pure Sunfarms is now proving itself as a leading cannabis brand, ranking as the number one selling dried flower brand by a wide margin with the Ontario Cannabis Store in October, and having the overall top selling dried flower product, as well as three of the seven top-selling dried flower product. We look forward to Pure Sunfarms building on this tremendous initial success as it launches its pre-rolled dried products, adds provincial supply agreements, starts its extraction operations online for the roll out of oils and other new product forms under Cannabis 2.0 in the first half of next year, and more than doubles its output, further supporting its low production costs.”

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) announced the release of its financial and operating results for the first quarter ended September 30, 2019.

The Company also announced that it has entered into a credit agreement with Bank of Montreal as Lead Arranger and Agent on behalf of a group of lenders for $90 million of senior secured credit facilities consisting of a term loan of $70 million and a revolving credit facility of $20 million.

“In the first quarter of fiscal 2020, we operated through challenging market conditions while integrating new businesses and product planning for the second half of the year. Overall, our financial results reflect the inherent difficulties of operating in a new regulated industry and the transitionary period we are in as we evolve from a predominantly wholesale business to a leading cannabis CPG company in Canada. Despite these challenges, in the quarter we improved production operations to generate industry-leading margins of 62% and made the strategic decisions necessary to position our businesses for meaningful revenue generation from flower, flower convenience products and select derivative products in the remainder of fiscal 2020,” said Navdeep Dhaliwal, CEO of Supreme Cannabis. “The closing of up to $90 million in credit facilities from tier one lenders is a significant achievement that positions the Company to execute on our strategy and prudently grow the business in fiscal 2020 and beyond.”

“In connection with the Credit Facility, the Company underwent a rigorous due diligence process to secure this favourable, non-dilutive financing from leading financial institutions,” continued Mr. Dhaliwal. “There is only a select group of Canadian federal license holders who have obtained such financing over the past year. In the current challenging operating environment, our ability to secure credit facilities with tier one lenders speaks to the strength of our management, business and operations, and our ability to deliver strong financial results.”

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced its financial and operational results for the first quarter of fiscal 2020 ended September 30, 2019.

“Over the past several years, Aurora has earned its place as a global leader in the cannabis industry. Despite short term distribution and regulatory headwinds in Canada that have temporarily impacted the industry, the long-term opportunity for Aurora in the global cannabis and cannabinoids market is immense,” said Terry Booth, CEO, Aurora Cannabis. “Aurora has, and will continue to focus on everything in our control. Our success in doing this was demonstrated again this quarter by continued strong improvement in our core KPIs. We delivered solid operating results this quarter, exemplified by our industry-leading cash cost to produce which declined another 25% to $0.85 per gram this quarter, as well as by our industry-leading gross margins and market share.”

Mr. Booth added, “In order to capitalize on this global market, we recognize the need to be nimble and proactive. To enhance our financial flexibility and position us to take maximum advantage of future growth opportunities, we have also taken decisive steps to immediately strengthen our balance sheet. Specifically, these steps include: (1) the announcement of a formal plan to settle our 5.0% convertible debentures due March 2020, (2) a reduction in our capital investments over the next several quarters by over $190 million to better match near-term capacity expansion with anticipated demand, while maintaining our long-term demand outlook, and (3) raising over US$124 million in gross equity proceeds since the start of fiscal 2020 through our at-the-market (“ATM”) financing program.”

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) reported its financial and operational results for the three and nine months ended September 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.

“Q3 marked TGOD’s entry into the recreational cannabis market with a small pilot in Ontario. We were thrilled to witness such positive feedback on product quality and packaging from retailers and consumers across the province. Based on the initial response, demand for high-quality flower is strong and TGOD is well positioned to capture the premium organic segment which is significantly underserved,” commented Brian Athaide, CEO of TGOD. “Despite the challenging market conditions in Canada, TGOD has an opportunity to be one of the first cash flow positive cannabis companies as early as Q2 2020. We rightsized our production and our first hybrid greenhouse is being commissioned, allowing us to produce at optimal levels while avoiding excess inventory or incurring unnecessarily high operating expenses. Our first harvest from the Ancaster hybrid greenhouse is expected in December, which will enhance our current product line and enable TGOD’s first material revenues in Canada in Q1 2020 which is very exciting,” continued Athaide.

Isracann Biosciences Inc. (CSE: IPOT) (formerly OTC: ATLED) (OTC: ISCNF) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, announced that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s request to change its OTC ticker symbol to ISCNF, effective as of the opening of market trading today, on November 15, 2019.

The previous trading symbol was ATLED and has been changed to more accurately represent our corporate brand and primary operations in the cannabis sector. The Company is also pleased to announce that it has secured DTC eligibility by The Depository Trust Company (“DTC”) for electronic settlement and transfer of its common shares in the United States.

“Trading under the new OTC ticker symbol ISCNF and achieving DTC eligibility is a major step forward in making it materially easier for US-based investors who are intrigued by the idea of buying shares in an Israeli cannabis venture operated by sector experienced entrepreneurs and capital markets professionals. Our strategic aim is straightforward and leverages the national brand excellence of the Israeli agricultural industry combined with planned industrial scale production of low cost premium quality cannabis targeting export into the massive European marketplace. It’s a uniquely scalable venture that combines numerous positive attributes including a team that knows how to execute,” stated Darryl Jones, Company CEO. “This is an important step in propelling our story to wider audiences and to materially grow our investor base.”

Auxly Cannabis Group Inc. (TSX.V: XLY), together with its wholly owned subsidiary Robinsons Cannabis Inc., announced Robinsons Outdoor Grow, a large scale, high quality outdoor cultivation project located in the heart of Nova Scotia’s award-winning wine region of Annapolis Valley.

Robinsons OG is uniquely located in a region that is ideal for outdoor cannabis cultivation given its diverse soil types and microclimates; the same soil on which the Acadians grew hemp over 250 years ago. Located within 25 kilometers of Robinsons’ 27,700 square foot indoor facility, Robinsons OG is comprised of over 158 acres of land in Hortonville, Nova Scotia and offers road frontage and highway access, allowing for the potential future development of tourism and point of sale opportunities.

Under the leadership of cannabis industry veteran Andrew Robinson, Robinsons OG will use a range of proprietary genetics with a track record of success in this climate and apply several outdoor growing techniques commonly used in the fruit crop production and wine industries.

The Robinsons OG project is of significant strategic value to Auxly, as it provides access to high-quality, sun grown cannabis flower for environmentally conscious consumers and a large amount of organic biomass at lower capital and operational costs and a lower carbon footprint relative to conventional indoor or greenhouse cultivation. The long-term, stable supply of outdoor cannabis produced on site at Robinsons OG will help support the product development initiatives at Dosecann Inc., the Company’s wholly owned 52,000 square foot facility located in nearby Charlottetown, Prince Edward Island. A substantial portion of the cannabis produced at Robinsons OG will be used to create premium, terroir-driven Robinsons-branded derivative cannabis products, with the same commitment to quality and craftsmanship as Robinsons’ dried flower.

Robinsons OG expects to submit its application and evidence of readiness to obtain a cultivation licence under the Cannabis Act from Health Canada in Q1 2020. The Company expects the capital expenditure for the buildout of Robinsons OG to be up to approximately $15 million (of which approximately $6 million has already been funded, with the remainder expected to be contributed through the first half of 2020), with expected yield of approximately 200 kilograms per acre. Robinsons OG expects to plant approximately 20 acres in the 2020 season and responsibly scale operations in the following years.

Hugo Alves, CEO of Auxly, commented: “We are thrilled to announce our Robinsons OG project. As you know, we are very excited to introduce Andrew’s incredible dried cannabis flower to discerning Canadian consumers and Robinsons OG provides us with the perfect platform from which to expand our Robinsons branded product offering. Under Andrew’s supervision, Robinsons OG will give us the ability to grow a broader range of Robinsons’ genetics, using Robinsons’ cultivation methodologies, and take advantage of the unique terroir of the Annapolis Valley to bring Canadian consumers Robinsons branded cannabis products, all produced with an unwavering commitment to quality and craftsmanship.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com – News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye .

Disclosure: this news article featuring DFLY is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclaimer/Disclosure: This news article/podcast featuring WMD is a paid for news release on Investorideas.com – third party (two thousand). Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411

$POAI Harnessing the Power of Artificial Intelligence to Improve Clinical Outcomes

$OGI Bill Filed in Illinois to Give Marijuana Industry Greater Access to Banking Services

November 15, 2019

Last week, an Illinois lawmaker filed a bill that would increase access to banking services for marijuana businesses. The number of financial institutions accepting to transact with marijuana-related businesses is increasing; however, the majority are still wary of doing business with cannabis businesses while cannabis remains federally illegal.

Now new legislation that would create a licensing process for banks and credit unions has been introduced by Democratic Representative Kambium Buckner. The bill would allow financial institutions to accept and issue special purpose checks for cannabis businesses.

The new legislation coincides perfectly with the comprehensive marijuana legalization bill, signed by the Illinois governor, which is set to take effect on January 1, 2020.

Although the legislation would have no effect on federal marijuana policy, it would help mitigate the risks that are faced by marijuana businesses operating on a cash-only basis by allowing licensed financial institutions to accept alternative methods of payments.

The new legislation assigns the responsibility of issuing the licenses to the Cannabis Banking and Credit Union Advisory Board.

The provisions of the bill include providing a safe and fast way to pay state and local fees and taxes, facilitating the payment of rent associated with marijuana business account holders as well as issuance of special purpose checks. The board would also have to invest in the state’s economy legally and reduce the burden of collecting and managing large sums of money from the local government.

Individuals or entities that have received limited marijuana charters or credit unions are expected to follow the Federal Bank Secrecy Act. They are also required to comply with the reporting guidelines for the Financial Crimes Enforcement Network.

The special purpose checks issued by the financial institutions can only be issued for the specific tasks as stipulated in the legislation. For example, paying off local and state taxes, rent, and issuing of bonds or warranties would only be allowed through these checks.

Marijuana limited charter banks and credit unions can form a network by entering into a contract. But, this would not prevent them from providing financial services to other businesses other than cannabis businesses.

The introduction of the new legislation finds Congress deep in the bipartisan legislation debates, which are meant to protect banks from being penalized by the federal regulators for transacting with marijuana businesses across the legal states. The SAFE Banking Act, which was approved by the House in September, is expected to secure Senate Banking Committee approval before the end of 2019.

In an interview with an online industry publication last week, the panel chairman, Senator Mike Crapo said that he is in support of holding a committee vote in the near future. But, he is suspicious of the House impeachment proceedings that could delay the marijuana banking vote.

Experts are of the view that cannabis businesses like ChineseInvestors.com (OTCQB: CIIX) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) may be hoping that this Illinois bill is enacted so that cannabis businesses can access some banking services.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

$TGODF Signs Arrangements for Up to $103 Million in Funding

• Proceeds to be used for completion of facilities at Ancaster and Valleyfield Phase 1
• Would provide bridge financing until TGOD becomes cash flow positive, expected by the end of Q2 2020
• TGOD to continue disciplined expansion across recreational markets in Canada

TORONTO, Nov. 14, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has signed arrangements for up to $103 million in funding. The financing package consists of three elements: a definitive agreement for a sale-leaseback of the Ancaster Energy Centre; a construction mortgage loan term sheet; and a convertible equity note term sheet.

“Our ability to raise capital, despite recent headwinds affecting the entire sector, is a clear show of confidence from our financial partners,” commented Brian Athaide, CEO of TGOD. “It is reflective of the value of our significant assets, the trust investors are putting into TGOD’s strong corporate governance, transparency and accountability, and the opportunity for the Company’s unique positioning to quickly capture and grow the organic segment.”

The Company has executed a definitive sale-leaseback agreement for the Ancaster Energy Centre, for proceeds of $23 million. It carries a term of 10 years after which TGOD is able to repurchase the energy centre for $1 and is non-dilutive. The closing of this definitive agreement is subject to the satisfactory completion of the purchaser’s financial due diligence and documentation of a concurrent Energy Services Agreement and Operating Agreement with the purchaser, an infrastructure investor. There can be no assurance that such conditions will be achieved or whether the closing will occur on the expected timeframe or at all.

A term sheet with an investment fund for a $40 million construction mortgage loan has also been signed, secured on the facilities at Ancaster and Valleyfield. The terms include $15 million payable on closing, with a $25 million additional advance available upon achieving certain operational milestones, which are expected later in 2020. The loan carries a 12% interest rate, an initial term of 2 years with the ability to extend further and is non-dilutive.

TGOD has also entered into a term sheet with an investment fund for a USD$30 million (~CDN$40 million) note with a 5% coupon, convertible into common shares of TGOD. Under the terms, TGOD would receive US$10 million upon closing with US$20 million immediately placed in escrow, to be released as the note is converted into common shares.

Closing of the two non-binding term sheets is subject to various conditions, including entering into legally binding documentation, satisfactory due diligence and the receipt of required regulatory approvals. The Company expects to close these transactions by the end of Q4, 2019, but there can be no assurance that the transactions close on that time frame or at all.

TGOD intends to use the proceeds from the financings to continue its rapid yet disciplined expansion with a focus on near-term profitability.

Raised capital will be used to:

• Complete construction of the processing facility at Ancaster.
• Complete construction of six zones in the Valleyfield hybrid greenhouse and enclose the balance of the facility with the ability to quickly expand production as the market develops.
• Provide adequate cash for working capital needs to bridge until the Company expects to generate positive operational cash flow.
• Achieve national distribution of TGOD products in early 2020.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a premium certified organic cannabis company focused on the health and wellness market.  Its certified-organic cannabis is grown in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards and its products are sold in recyclable packaging.  In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about construction and future production, statements about the potential to achieve positive EBITDA, statements about timing or likelihood of closing of financings, statement about the availability of future financing tranches, statement about potential to receive regulatory approvals, statement about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “should”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements, including those risk factors described in the Company’s most recently filed Annual Information Form available on SEDAR. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX nor the TSX’s Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$SRAX BIGtoken Platform 16 Million-Plus on Opt-In Data Management

• To date, more than 16 million consumers around the world have joined; that number increases daily
• SRAX offers other powerful data-management tools

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has had more than 16 million consumers opt-in to its BIGtoken consumer-managed data platform since the product was released earlier this year. In addition, SRAX offers other powerful products designed to provide marketers and consumers with the tools to unlock the value of data.

During an interview at SNNLive at the Planet MicroCap Showcase 2019 in Las Vegas, SRAX CEO and co-founder Christopher Miglino was asked about the “secret sauce” to getting such a high response rate…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$LXRP Announces Closing of Non-Brokered Private Placement

Kelowna, British Columbia – November 14, 2019 – Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has closed the first tranche of its previously announced private placement of units (the “Offering”) as at November 13, 2019.

Pursuant to the Company’s news release of October 30, 2019 the Company announces that it has closed this tranche of its Offering and has received gross proceeds of US$699,410.25 from the sale of an aggregate 1,554,245 units (“Units”) at a price of US$0.45 per Unit. Each Unit is comprised of one common share (“Share”) and one share purchase warrant (“Warrant”) whereby the holder of a Warrant will be entitled to exercise the Warrant to purchase an additional Share (“Warrant Share”) at a price of US$0.80 until November 13, 2020 and thereafter at a price of US$1.20 until November 13, 2021 (the “Expiry Date”). The Warrants will expire and will no longer be exercisable after the Expiry Date.

The Company also paid US$3,937.50 and issued 8,750 warrants (the “Broker Warrants”) to certain finders in connection with the investment by investors of an aggregate 125,000 Units. The Broker Warrants have the same exercise terms and Expiry Date as the Warrants.

The net proceeds received from the Offering will be used as to US$200,000 for continued research and development of the Issuer’s DehydraTECH technology; US$50,000 for sales and marketing of the Issuer’s products; US$50,000 for finance and legal fees; US$75,000 for pursuing patent applications; US$170,000 for general working capital and US$150,000 for administration costs.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.

www.lexariabioscience.com

$SGLB Sigma Labs Reports Third Quarter 2019 Financial Results

Recent Progress with OEMs, End Users and Additive Manufacturing Integrators Position Sigma for Commercial Revenue Growth in 2020

SANTA FE, NM / November 14, 2019 / Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs”), a leading developer of quality assurance software for the commercial 3D printing industry, reported its financial and operational results for the third quarter ended September 30, 2019.

Key Third Quarter 2019 and Subsequent Highlights

• Awarded two-machine contract and selected for Phase 2 test and evaluation program of PrintRite3D^® in-process quality assurance software by leading global energy technology company.
  • Customer provides technology and services that enable oil and gas companies in over 120 countries to deliver safe, affordable energy to the world.

• Selected by major Japanese OEM machine tool manufacturer for a test and evaluation program of PrintRite3D real time melt pool analytics at OEM’s R&D center in Japan.
• Awarded contract by VTT Technical Centre of Finland to install PrintRite3D at the VTT 3DMetalprint Centre for Additive Manufacturing, enabling VTT to best support its customers development activities.

• Chief Technology Officer Darren Beckett to demonstrate PrintRite3D on-site and speak at Formnext 2019 – the leading global exhibition on additive manufacturing and the next generation of intelligent industrial production in Frankfurt, Germany on November 19-22, 2019.
  • CTO Darren Beckett will also present on the integration of PrintRite3D into Materialise’s MCP control system in the Materialise (NASDAQ:MTLS) Booth at Formnext 2019.

• Selected by a major international OEM machine manufacturer to deploy two PrintRite3D quality assurance software programs as part of an evaluation process for a broader rollout.
• Selected by Airbus (AIR:FP / OTC: EADSY), a global leader in aeronautics, space and related services to deploy the PrintRite3D version 5.0 software product into a fusion printer as part of a testing and evaluation program ahead of a larger potential commercial rollout throughout the Airbus organization.

• Results from testing and evaluation (“RTE”) programs underway through the end of the third quarter of 2019 have shown favorable results:
  • Global energy technology company – Phase 1 RTE successful, proceeded to final, Phase 2 RTE;
  • Major contract manufacturer – Initiated second Phase 1 RTE program on new machine type, following up on success of initial Phase 1 RTE from March 2019;
  • Major international OEM machine manufacturer – Accelerated Phase 1 RTE underway;
  • Airbus – Phase 1 RTE successfully underway, anticipate Phase 2 RTE by end of Q4 2019; and
  • Materialise – Phase 1 RTE successfully underway with Materialise, anticipate Phase 2 RTE by end of Q4 2019.
    • Materialise has requested Sigma’s Chief Technology Officer to lead a public talk on the implementation of PrintRite3D with Materialise’s MDC Control System.

• PrintRite3D Patent Estate: Expanded its robust intellectual property portfolio to 34 issued and pending patents both domestically and internationally, with notices of allowance for two issued patents received as recently as November 2019.
• Showcased PrintRite3D quality assurance software at the Additive Manufacturing Conference 2019, in Austin, Texas on August 27-29.

• Appointed accomplished financial executive Frank D. Orzechowski as Chief Financial Officer, bringing over 30 years of operational experience to the Sigma Labs team.

• Engaged leading international investor relations specialists MZ Group to lead a comprehensive strategic investor relations and financial communications program across all key markets.

Management Commentary

“The third quarter of 2019 was highlighted by continued success in engaging both OEMs and end-users as PrintRite3D customers, driving continued industry awareness and developing promising commercial opportunities,” said John Rice, Chairman and Chief Executive Officer of Sigma Labs.

“Notably, we were recently selected by a major Japanese OEM machine tool manufacturer entering the commercial metal 3D printing market, as well as an unnamed major international OEM machine manufacturer, to deploy PrintRite3D systems for their respective evaluation programs. We believe a partnership to integrate our technology at the OEM level for any major additive manufacturing machine OEM, such as those we are in evaluations with now, could drive notable license revenue growth in the short term and very significant pass-through revenue from the OEM’s customers in the mid and long term. We are pleased and encouraged by the robust interest we continue to see from industry OEMs and look forward to providing our shareholders with an update as these evaluations progress over the next several months.

“On the end-user front, we continue to see intense interest in PrintRite3D as manufacturers seek to reduce their quality risks, material waste, and uncertainty and expense of post-process inspection from their additive manufacturing processes. Recently announced global energy technology company, and our second major Test and Evaluation customer, has now placed an order for Phase 2 deployment of our technology which they have advised Sigma will enable them to determine if our equipment should be integrated into their serial production equipment. We expect Phase 2 testing and evaluation to take substantially less time than Phase 1. Our third major end-user and contract manufacturer is also having us deploy our technology on a second round of equipment. Airbus (AR.PA), an international aerospace company, was our fourth major announcement on the end-user front and substantial progress has been made implementing IPQA^® to ensure process quality by identifying thermal signatures of defects found in both process and parts. On the integration front, we recently partnered with VTT Technical Centre of Finland, who leads international research and technology adoption for private and public sectors. We believe that our two-pronged commercialization model, targeting both additive manufacturing machine OEMs as well as end-users, will allow us to most rapidly aggregate market share while most efficiently monetizing our incredible quality assurance software,” continued Rice.

“On a new front, commencing in June 2019, Sigma opened a third channel to market with the release of PrintRite3D^® 5.0. Sigma brought a user-friendly version of its product to market that no longer requires substantial onsite customer support from Sigma. Therefore, the company commenced calling on research tanks, universities and small users to open a ‘retail’ channel. As of today, the pipeline of signed purchase orders (PO) in the channel total $317,000 and we have verbal commitments for PO’s totaling approximately $895,000.

“In terms of broader industry awareness, we are undertaking several exciting initiatives to share the numerous success stories from our PrintRite3D technology. Ron Fisher, our Vice President of Business Development, hosted successful PrintRite3D demonstrations for high-level industry executives in Austin, Texas at the Additive Manufacturing Conference 2019 in late August. In addition, our Chief Technology Officer Darren Beckett will showcase our PrintRite3D technology later this month at Formnext 2019, the additive manufacturing sector’s premier global exhibition in both the Sigma Labs’ booth as well as in the booth of our strategic partner and leading 3D printing solutions provider, Materialise. We are particularly excited about Formnext 2019 and the immense commercial potential that could stem from this event.

“We continue to align ourselves with thought leaders in the additive manufacturing space and I believe our partnership with VTT Technical Centre of Finland is a testament to this, as they enter in our PrintRite3D installation and testing network of our third party Additive Technology resources and influencers composed of the Fraunhofer Institute in Germany, the Manufacturing Technology Center in England and the National Institute of Standards and Technology (NIST) in the U.S. As part of that VTT contract win, we beat out a major global additive manufacturing machine OEM in a head-to-head technology comparison that scored our competitor as ‘unable to perform’ key features provided by PrintRite3D^®. To work with an organization like VTT, an established innovation leader supporting leading brands worldwide through their 3D metal printing facility, is particularly exciting as it opens the door to their innovation-centric customer base.

“A very important asset that I believe separates us from the competition as we ramp up commercialization is our broad span of intellectual property comprising numerous trade secrets, nine patents granted, and 25 pending in both the U.S. and around the globe. A year ago, today, we didn’t have a fully hardened and fully user-friendly commercial product to sell and in 12 short months, we now have a hardened commercial industrial user-friendly product with 19 beta customers who are some of the largest industrial companies on the planet and in the top echelon of additive manufacturing OEMs,” explained Rice.

“We are also seeing increasing momentum from major industry players into the fourth quarter and believe that as our initial testing and evaluation programs come to a close, such as those with Airbus, our recently announced global energy technology company or our unnamed end-user as well as the additive manufacturing machine OEM partners, we believe we will begin to secure noteworthy commercial orders as they aggressively roll-out our technology organization-wide. Current evaluation programs underway, when paired with the business development in queue for Formnext 2019, provides me with a high level of confidence in our ability to scale revenues significantly into 2020 and beyond.

“Additive manufacturing is, in our mind, undoubtedly the next industrial revolution and we are on the forefront of revolutionizing an essential element for its widely forecast leap to serial manufacturing. The flexibility inherent to additive manufacturing, combined with the increased quality and decreased risks, waste and costs accomplished with our PrintRite3D technology, create an unbeatable combination. A recent study by E&Y found that an incredible 78% of aerospace companies already leverage this technology for high-value applications, while the opportunity for additive manufacturing in serial production is immense and will continue to grow as costs for the technology continues to come down over time, in part due to the level of savings that our PrintRite3D quality assurance software provides.

“I look forward to sharing our story with the investment community at the upcoming LD Micro Main Event on December 10^th in Los Angeles, California. There is an immense opportunity facing Sigma Labs today and I am eager to execute upon it, creating sustainable long-term value for our shareholders,” concluded Rice.
Third Quarter 2019 Financial Results

Revenue for the third quarter of 2019 was $171,003, as compared to $128,593 in the third quarter of 2018. Under the company’s 2019 RTE program, the company has outlined the following near-term revenue pipeline:

• RTE Program: The revenue potential from the conversion of a single unit test run into a permanent license sale is as follows and assumes $125,000 for a single unit:
  • $25,000 upon executing the RTE and $100,000 after the phase 1 RTE is completed to buy the equipment. Management estimates that a successful follow-on Phase 2 RTE on two or three additional units may result in upwards of $250,000 to $375,000 in revenues.

• End-User: Potential revenue realizable from a successful RTE that leads to deployment on production line equipment ranges between $2.0 million – $4.0 million per average major end-user. Management estimates that at least three RTE end-user companies will determine in Q4 2019 and 2020 whether to launch deployment of PrintRite3D 5.0 on their production equipment.
• OEM Engagements: Management estimates based upon current engagements that no less than three OEM’s will determine whether to seek licenses for Sigma Labs’ PrintRite3D with meaningful license revenue potential for 2020, and significant potential in 2021. These licenses all have annual maintenance recurring revenue options.

• Retail (Research – Universities): As of today, the pipeline of signed purchase orders (PO) in the channel total $317,000 and we have verbal commitments for PO’s totaling approximately $895,000.

Gross loss in the third quarter of 2019 was $7,757, as compared to a gross profit of $72,284, or 56.2% of revenues, in the third quarter of 2018. The decrease in our gross margin is primarily attributable to the additional travel and labor costs associated with the on-site and remote collaboration involved in the growth of the company’s Test and Evaluation programs.

Total operating expenses were $1.6 million in the third quarter of 2019, as compared to $1.4 million in the third quarter of 2018. The company added two application engineers, two software engineers and one business development employee during the first nine months of the year. Our current employee headcount is expected to be sufficient through the first half of 2020.

Cash used in operating activities was $4.5 million for the nine months ended September 30, 2019 compared to $2.7 million in the nine months ended September 30, 2018.

• The company made a considerable investment in inventory through the first three quarters of 2019 due to increased new RTE programs, expansion of existing programs, and PrintRite3D sales resulting from the new “retail” market channel. Total inventory has increased from $240,086 at the end of 2018 to $712,587 at September 30, 2019.

• Additional spending in internal research and development through September 30^th was related to our continued acceleration of technology development of Version 5.0 of our PrintRite3D^® platform.

• Management expects cash usage to decrease during the fourth quarter of 2019 as major initiatives in these areas have been completed.

Net loss in the third quarter of 2019 totaled $1.6 million, or $(0.12) per share, compared to a net loss of $1.3 million, or $(0.16) per share, in the third quarter of 2018.

Cash totaled $1.1 million at September 30, 2019, as compared to $0.7 million at June 30, 2019 and $1.3 million at December 31, 2018. Sigma Labs completed a $2.3 million public offering of common stock on August 2, 2019.

“The foundation building for our PrintRite3D commercial launch has largely been completed from a financial perspective in the third quarter of 2019,” said Chief Financial Officer Frank Orzechowski. “Notable improvements to our sales infrastructure and channels have been made that resulted in several new RTE programs which can be seen in our growing inventory metric and why we thought it was important to articulate the multiple revenue opportunities currently underway with licensing partners and end-users. Moreover, in the fourth quarter, the pipeline of verbally committed and or signed purchase orders in the channel currently totals $1.2 million. I am also happy to report that we are in active negotiations with OEM partners for strategic alternatives who currently see the immense value in our enterprise and look forward to providing an update on that front as they develop,” concluded Orzechowski.

Third Quarter 2019 Results Conference Call

Sigma Labs will hold a conference call today at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. Sigma Labs Chairman and CEO John Rice and CFO Frank Orzechowski will host the conference call, followed by a question and answer period.

To access the call, please use the following information:

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.

The conference call will be broadcast live and available for replay at http://public.viavid.com/index.php?id=136449 and via the investor relations section of the Company’s website at www.sigmalabsinc.com.

A replay of the conference call will be available after 7:30 p.m. Eastern time through November 28, 2019.

About Sigma Labs

Sigma Labs, Inc. (NASDAQ:SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D® for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.sigmalabsinc.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on April 1, 2019 and which may be viewed at www.sec.gov.

Investor Contact:

Chris Tyson
Managing Director
MZ Group – MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us

Sigma Labs, Inc.
Condensed Balance Sheets
(Unaudited)

Sigma Labs, Inc.
Condensed Statements of Operations
(Unaudited)

Sigma Labs, Inc.
Condensed Statements of Cash Flows
(Unaudited)

SOURCE: Sigma Labs, Inc.

$CNPOF $RIV.V Q2 FY20 Financial Results and Corporate Update

TORONTO, Nov. 14, 2019 – Canopy Rivers Inc. (the “Company” or “Canopy Rivers“) (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and six months ended September 30, 2019 (“Q2 2020“). The Company’s unaudited condensed interim consolidated financial statements for Q2 2020, and its management’s discussion and analysis for Q2 2020 (the “Q2 2020 MD&A“), are available under the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR“) at www.sedar.com and on the Company’s website at www.canopyrivers.com/investors/financials-and-public-filings. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

“Headlined by our graduation to the TSX, our business matured during the second quarter as we launched our Strategic Advisory Board and continued to work closely with our portfolio companies as they achieved new milestones,” said Narbé Alexandrian, President & CEO, Canopy Rivers. “There were numerous achievements for our portfolio companies this quarter. Several of these companies received licences and amendments from Health Canada for the sale of cannabis oils, while others made key acquisitions, launched their Canadian business, or brokered agreements with companies both inside and outside of the Canopy Rivers ecosystem. As we move forward, we plan to continue to develop a robust ecosystem of mutually beneficial cannabis companies intended to drive the industry forward and lay down the foundation for long-term success.”

Q2 2020 Financial Results¹

“Although the cannabis industry experienced challenging capital markets conditions during the quarter, our view is that the underlying positive momentum across the sector globally will help propel disciplined companies through these headwinds,” said Eddie Lucarelli, Chief Financial Officer, Canopy Rivers. “We believe that a strong balance sheet and a continually maturing market create optimal conditions for investment opportunities for Canopy Rivers. We remain focused on our business model of providing capital to the disruptors of the cannabis industry, while maintaining a thesis-driven approach to investment decisions and keeping long-term value creation for our shareholders front of mind.”

During the quarter ended September 30, 2019, Canopy Rivers generated operating income of $930 thousand, primarily driven by royalty, interest, and lease income of $2.2 million from: royalty and debenture agreements with Agripharm Corp., 10831425 Canada Ltd. d/b/a/ Greenhouse Juice Company, James E. Wagner Cultivation Corporation (“JWC“), and Radicle Medical Marijuana Inc. (“Radicle“); a lease agreement with Spot Therapeutics Inc. (“Spot“); and a shareholder loan agreement with PharmHouse, Inc. (“PharmHouse“). This income was partially offset by a $559 thousand net decrease in the fair value of certain financial assets that are reported at fair value through profit or loss. Operating income was further offset by a $682 thousand share of loss from the Company’s equity method investees. This share of loss was recorded one quarter in arrears, which includes the Company’s common equity positions in Canapar Corp., 10663522 Canada Inc. d/b/a Herbert Works (“Herbert Works“), High Beauty, Inc., LeafLink Services International ULC, PharmHouse and Radicle. Management expects these equity method investees to continue to generate net losses during the remainder of the Company’s fiscal year as they continue to ramp up operationally.

Operating expenses for the quarter were $6.2 million, of which $3.0 million (or approximately 48% of the total) related to share-based compensation. As with previous reporting periods, a significant portion of this non-cash expense is related to options granted to non-employees, which occurred at an early stage in the Company’s growth and requires remeasurement each period. Other operating expenses, which include consulting and professional fees and other general and administrative expenses, were $3.2 million, representing an increase from the comparative quarter last year due to the build-out of the Company’s management team and employee base and enhanced public company compliance, marketing and business development, and regulatory costs. Other operating expenses also increased from the previous quarter due to certain non-recurring costs relating to the Company’s graduation to the Toronto Stock Exchange (“TSX“) and the launch of a formal branding and marketing campaign.

Other comprehensive income, which captures the net changes in fair value of financial assets that are reported at fair value through other comprehensive income, was a loss of $28.3 million, net of tax. The fair values of Canopy Rivers’ investments in Eureka 93 Inc., JWC, YSS Corp. (“YSS“), Les Serres Vert Cannabis Inc. and TerrAscend Corp. (“TerrAscend“) were negatively impacted by downward trends in public market valuations for cannabis companies during the period.

Q2 2020 Corporate and Portfolio Updates

The following represents a brief summary of the milestones achieved by Canopy Rivers and/or its portfolio companies during the quarter ended September 30, 2019:

• Canopy Rivers graduated from the TSX Venture Exchange and began trading on the TSX under the trading symbol “RIV”.
• Canopy Rivers launched its Strategic Advisory Board to provide guidance and value to the Company’s executive team as it continues to build and strengthen the Company’s portfolio.
• TerrAscend acquired Ilera Healthcare, a vertically-integrated cannabis cultivator, processor, and dispensary operator in Pennsylvania; and entered into an agreement to acquire a California cultivator that owns premium cannabis flower brand, State Flower.
• TerrAscend Canada Inc. (“TerrAscend Canada“), a wholly-owned subsidiary of TerrAscend, entered into a distribution agreement with Syqe Medical, Ltd., an Israel-based pharmaceutical-technology company, to launch the Syqe™ Inhaler in Canada. TerrAscend Canada also commenced sales to Europe through its German distribution partner, becoming the first, and, to management’s knowledge, only cannabis company with sales in Canada, the U.S., and the European Union. Finally, Health Canada granted TerrAscend Canada an amendment to its licence allowing for the sale of cannabis oils, which it intends to facilitate through its online medical sales platform, Solace Health.
• Herbert Works received a research and development licence from Health Canada to develop cannabis-infused beverages.
• Headset, Inc. launched Headset Insights in Canada, with Alberta signing on as the first province to access the product. YSS also adopted Headset Insights to gain data and insights related to consumer behavior.
• YSS received its 12^th cannabis retail licence in Alberta, and now has 12 licensed- operating stores located throughout the province.
• Radicle received approval from Health Canada for its production facility expansion project, effectively doubling its production capacity.
• PharmHouse received a cultivation licence from Health Canada for 190,000 square feet of licensed nursery infrastructure. Subject to approval from Health Canada, PharmHouse plans to ramp up its entire 1.3 million square foot greenhouse in the coming months.
• JWC received a licence amendment from Health Canada allowing for the sale of cannabis oils from JWC’s pilot facility in Kitchener, Ontario. Through a collaboration developed alongside Canopy Rivers, JWC also entered into a purchase and sale agreement with TerrAscend Canada, pursuant to which JWC has agreed to supply cannabis flower and oils to TerrAscend Canada that will be sold online through Solace Health.

Subsequent Corporate and Portfolio Updates

Subsequent to the end of the quarter, Canopy Rivers and its portfolio companies reported several achievements:

• Radicle signed an agreement with Spectrum Therapeutics (“Spectrum“), Canopy Growth Corporation’s medical cannabis distribution platform, to make Radicle’s products available through Spectrum. Radicle also received approval for cannabis oil sales from Health Canada.
• Canopy Rivers partnered with Kindred Partners Inc. (“Kindred“), a wholly-owned subsidiary of Breakthru Beverage Group, to provide the Company and its portfolio companies with access to Kindred’s brokerage, marketing, and brand-building services. Immediately following this announcement, TerrAscend Canada and Kindred announced the formation of a brokerage partnership pursuant to which Kindred will serve as the exclusive broker for TerrAscend Canada’s adult-use cannabis products in Canada.
• YSS entered into a definitive agreement to acquire a licensed cannabis retail operator in Swift Current, Saskatchewan, marking the first step in its anticipated expansion outside of Alberta. The retail location in Swift Current will be branded under its “Sweet Tree” banner.
• Canopy Rivers advanced $13.5 million to Spot pursuant to the terms of a repayable debenture. This amount was immediately set-off against the purchase price of a royalty interest pursuant to the terms of a royalty agreement between Canopy Rivers and Spot, which initiated a long-term cash flow stream that is anticipated to result in a minimum annual payment of approximately $2.85 million over a 25-year term.
• JWC received a Health Canada licence amendment allowing for cannabis production in four new flowering rooms at its flagship facility, and a Health Canada sales licence for cannabis edibles, extracts, and topicals.
• Canopy Rivers completed a US$10 million loan to TerrAscend Canada. Following completion of the transaction with TerrAscend Canada and discussions with the TSX, the Company intends to make certain amendments to the terms of the transaction regarding the conversion rights, form of interest payments and guarantee provisions. The net proceeds are expected to be used by TerrAscend Canada for general corporate purposes and will not be used, directly or indirectly, in connection with any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States.
• TerrAscend Canada received approval from Health Canada for an expansion at its Mississauga, Ontario facility. The approval nearly tripled TerrAscend Canada ‘s licensed space to 51,800 square feet, and the expanded space includes additional cultivation capacity, a commercial kitchen, formulation rooms, and increased primary and secondary packaging capacity. TerrAscend Canada also received a Health Canada sales licence for cannabis edibles, extracts, and topicals.

For more information regarding the Company and its portfolio companies, please refer to the Q2 2020 MD&A and the Company’s annual information form dated July 15, 2019 (“AIF“), filed with the Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the Company’s plans, activities  and expected future focus; the anticipated benefits of the Company’s Strategic Advisory Board; the anticipated impact of challenging capital markets volatility and positive momentum across the global cannabis sector; expectations that the Company’s balance sheet and market conditions create an optimal condition for investment opportunities for Canopy Rivers, expectations of return on the Company’s investments; expectations for the Company’s creation of long term value creation for shareholders, management’s expectation that equity method investees will continue to generate net losses during the remainder of the Company’s fiscal year; the ability of the Company’s investees to leverage strengths within the Canopy Rivers ecosystem in order to accelerate individual paths to success and create value for the Company; TerrAscend Canada’s intention to sell cannabis oils through its online medical sales platform, Solace Health; the expected increase in Radicle’s production capacity; the planned sale of Radicle’s products on Canopy Growth Corporation’s medical cannabis distribution platform, Spectrum; PharmHouse’s plans to ramp up its entire 1.3 million square foot greenhouse in the coming months; JWC’s supply of cannabis flower and oils to TerrAscend Canada and the sale of such products on Solace Health; the anticipated annual minimum cash flow stream to the Company from Spot; YSS’s expansion plans outside of Alberta; the anticipated increase in TerrAscend Canada’s licensed facility; the Company’s intention to make certain amendments regarding its loan to TerrAscend Canada; TerrAscend Canada’s anticipated use of net proceeds received from the Company; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; competition; changes in cannabis industry growth and trends; changes in the focus, business activities and plans of the Company and its investees and the timing associated therewith as well as the impact and/or benefits thereof; the Company’s actual financial results and ability to create long-term value for shareholders; the ability of Canopy Rivers’ investees to collaborate; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in the Company’s relationship with Canopy Growth Corporation and its portfolio companies; changes in applicable laws; compliance with extensive government regulation, including the Company’s interpretation of such regulation; changes in the global sentiment towards, and public opinion of, the cannabis industry; divestiture risks; and the risk factors set out in the Company’s AIF, filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

$YGYI Postpones Third Quarter and Nine-Month Results Conference Call

SAN DIEGO, Nov. 13, 2019  — Youngevity International, Inc. ( NASDAQ :YGYI ) (www.ygyi.com) a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, announced today it is rescheduling its Third Quarter and Nine-Months Ending September 30, 2019 earnings release and earnings call to allow the company additional time to complete the review of its Form 10-Q. The conference call was previously scheduled for Wednesday, November 13, 2019 at 1:15 PM PST. The Company will issue a press release announcing the specific date and time of the rescheduled Third Quarter 2019- and Nine-Months Ending September 30, 2019 earnings call upon completion of this review.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a multi-channel lifestyle company operating in 3 distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise.  The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI Investor Relations
800.504.8650
investors@ygyi.com

$POAI AI-Driven Predictive Models Rapidly Changing Landscape of Cancer Treatment

• POAI subsidiary Helomics announce sequencing of ovarian tumor cases from UPMC Magee collaboration, a critical step in strategic Cancer Quest 2020 initiative
• Data key to value in $48-billion precision-medicine industry
• Industry leaders such as POAI realize critical value in patient-specific, data-driven models

The field of drug development for cancer treatment involves costly and time-intensive research. As technology plays an ever-increasing role in driving medicine, researchers and clinicians are discovering the significant potential of patient-derived models in matching specific cancer types with their most effective treatments. These models, which harness the patients’ own cancer cells to best determine how to defeat them, have been shown to be “a valuable tool for the identification of new treatment targets” (http://nnw.fm/BI5pI). To prepare for this next major frontier of precision medicine, industry leaders realize the critical value in these patient-derived (PDx) models of cancer. While most competitors are just getting their feet wet in both developing these PDx models and generating data from them, Predictive Oncology Inc. (NASDAQ: POAI) has been swimming in the deep end for some time, boasting an immensely valuable historic database of drug response for patients from its own proprietary PDx tumor models.

In the precision-medicine industry, the value of any predictive model is directly related to the quality and quantity of data used to build it. The richer and more extensive a predictive model’s data set, the more accurate and generalizable the predictions become. This predictive value translates into…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$OGI Wisconsin State Officials Say Federal Hemp Rules Unlikely to Affect 2020 Planting Season

November 13, 2019

According to agriculture officials in Wisconsin, the 2020 planting season will not be affected by the new federal rules on industrial hemp. Last week, the USDA released an interim final rule for establishing the Domestic Hemp Production Program. The USDA was mandated by the 2018 U.S. Farm Bill to develop federal regulations for industrial hemp growth.

The released interim final rule provides guidelines on the record-keeping system for easy access to information, testing procedures, disposal of plants not below 0.3% THC content, and licensing requirements for the state and tribal hemp programs. The rules also establish federal plans for growers in states or territories of Indian communities that do not have an approved hemp production program.

The 2019 planting season in Wisconsin was the second year growing industrial hemp under the state Department of Agriculture, Trade and Consumer Protection hemp research pilot program in Wisconsin.

The Agency is reviewing the new regulations to determine how they will affect the current hemp program rules, said Sara Walling, the administrator of DATCP’s Agricultural Resource Management division.

Walling further said that the agency has several ways through which the new regulations align with the Wisconsin hemp program regulations, such as the testing for THC in hemp. She also noted that there other provisions in the interim final rule that require the USDA to do a lot of research, consideration, and debate. The new rules stipulate that the Wisconsin hemp program works with the USDA’s Farm Service Agency (FSA) to issue cultivation licenses.

The DATCP officials and the legislators will be working together to ensure that it will be possible to make the necessary amendments under the legislation meant to update the state’s pilot hemp program.

However, the new changes will not impact the growers and processors during next year’s planting season, Walling said.

Walling said that the 2020 planting season will operate under the 2014 Farm Bill because the agency is still assessing and considering all the parameters presented to them through the legislation, which is currently being debated by lawmakers.

She further said that the state of Wisconsin is supposed to submit its hemp program proposal and get authorization from the USDA by October 13, 2020.

The rules are clear to understand for producers, and it is a step in the right direction for the hemp industry, said Ken Anderson, the CEO of Legacy Hemp Holdings, Inc. He also noted that the production of seed and fiber would not be affected by the changes in THC testing. But Anderson hopes that hemp grown for fiber and seeds would not be subjected to the stringent measures such as those of hemp for CBD.

Although the USDA rule has established some crop insurance and loan programs for hemp farmers, Anderson said that banks and insurance sectors are still wary of conducting business with industrial hemp businesses.

The general counsel for the Wisconsin Hemp Alliance, Larry Konopacki, said that the USDA plan to be actively involved in regulating state programs is disappointing because they thought that the federal rule would grant them the opportunity to design their program as they see fit.

Konopacki also said that the final interim rule would make growing hemp a challenge for Wisconsin growers by imposing strict testing requirements for THC.

Experts think that the reassurance that the 2020 planting season in Wisconsin will not be guided by the federal hemp rules is a welcome move in the eyes of industry actors like Marijuana Company of America Inc. (OTCQB: MCOA) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) who could prefer a phased manner of introducing new regulations.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$LXRP Advances Development of Proprietary Drug-Delivery Platform

$SGLB Awarded Phase 2 RTE Contract by Leading Global Energy Tech Provider